Pioneering Clinical Study Shows Unique Resveratrol Delivery Matrix Is Orally Bioactive



A university clinical study accepted for presentation at the Annual Meeting of the American College of Sports Medicine, Southeast Chapter in February, 2008 shows that Longevinex, a patent pending natural resveratrol delivery matrix, can exert positive effects in relation to endurance exercise-induced markers of physiologic stress.

Steven R McAnulty, Ph.D., Associate Professor in the Health, Leisure, and Exercise Science department at Appalachian State University, led the study, which was completed in May of 2007. "To date, there do not appear to be any human studies indicating that oral consumption of resveratrol - containing dietary supplements can produce favorable changes in markers of oxidative stress or inflammation. We were surprised by our findings and look forward to presenting them in mid-February," offered Dr. McAnulty.

Dr. McAnulty is one of the co-authors of two recent articles showing that high dose (1,000 mg/day) quercetin-a constituent of Longevinex, albeit present in a much lower quantity (25 mg)-can reduce upper respiratory tract infection in endurance cyclists yet without an apparent effect on muscle inflammatory cascade responses, during a period of intense training.

Longevinex is a dietary supplement innovation marketed exclusively by Resveratrol Partners, LLC, with distribution based in Las Vegas.

"An abundance of data show that resveratrol - in its pure chemical form, or in dietary supplement delivery systems - is 'stability challenged'," offered Bill Sardi, president of Resveratrol Partners and a noted health journalist and book author. "Our patent pending composition is far more than just resveratrol - it is designed to be a stable and reproducibly effective oral delivery matrix for resveratrol but exerting greater bioactivity than resveratrol or 'resveratrol extracts' alone. Our ongoing preclinical research program has also yielded some very exciting data - with noted superiority over synthetic, pure resveratrol alone. These data will be unveiled by the middle of 2008," he added.

Resveratrol Partners, LLC is an innovation and science-driven dietary supplement marketer engaged in direct to consumer marketing. Longevinex is the first dietary supplement marketed by the company. The pilot study was supported by grants from Appalachian State University Research Council and the Vaughn Christian Research Endowment. Resveratrol Partners LLC donated the dietary supplements.

Preliminary findings from resveratrol and catechin pilot study with abstract submitted to Southeast American College of Sports Medicine annual meeting.

Effects Of Resveratrol And Catechins With Exhaustive Exercise On Oxidative Stress And Inflammatory Markers

Lindsey E. Schreiber, Steven R. McAnulty, Lisa S. McAnulty, Peter A. Hosick, Jenna L. Wreiden, Mathew B. Hudson, John C. Quindry, David C. Nieman, and Dru A. Henson. Departments of Health, Leisure, and Exercise Science, Family and Consumer Sciences, and Biology; Appalachian State University, Boone, NC 28608

Contact:

Bill Sardi

President

Resveratrol Partners LLC, dba Longevinex

Tel: 909 596 9507





Pioneering Clinical Study Shows Unique Resveratrol Delivery Matrix Is Orally Bioactive